Advertisement
Canada markets open in 6 hours 15 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7312
    -0.0009 (-0.12%)
     
  • CRUDE OIL

    83.48
    +0.12 (+0.14%)
     
  • Bitcoin CAD

    91,383.01
    +572.95 (+0.63%)
     
  • CMC Crypto 200

    1,417.41
    -6.69 (-0.47%)
     
  • GOLD FUTURES

    2,337.70
    -4.40 (-0.19%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • NASDAQ futures

    17,737.75
    +131.00 (+0.74%)
     
  • VOLATILITY

    15.69
    0.00 (0.00%)
     
  • FTSE

    8,077.27
    +32.46 (+0.40%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6838
    +0.0002 (+0.03%)
     

Why BioCryst Pharmaceuticals Stock Is Soaring Today

Why BioCryst Pharmaceuticals Stock Is Soaring Today

Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) were up by a healthy 14% as of 1:40 p.m. ET Wednesday. Although it missed Wall Street's consensus top-line estimate by $2.6 million for the quarter, investors appear to be more concerned about BioCryst's overall financial health and near-term outlook. BioCryst said that in Q1, the number of U.S. patients taking its oral hereditary angioedema (HAE) drug Orladeyo rose by 46% year over year.